Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LEGN stock hub

Legend Biotech Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LEGNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LEGN

In the news

Latest news · LEGN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E104

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-29.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-30.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LEGN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001801198
Company name	Legend Biotech Corporation
Country	United States
Country code	US
Cusip	52490G102
Employees	2,965
Employees Change	356%
Employees Change Percent	13.65
Enterprise value	$4.7B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-06-05
Isin	US52490G1022
Last refreshed	2026-05-10
Market cap	$5.2B
Market cap category	Mid-Cap
Price	$28.12
Price currency	USD
Rev Per Employee	347,015.18x
Sector	Healthcare
Sic	2834
Symbol	LEGN
Website	https://legendbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.71%
EV Sales Forward	3.2x
EV/Sales	4.53x
FCF yield	-2.48%
Forward P/E	104.04x
P/B ratio	5.19x
P/S ratio	5.05x
PS Forward	3.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.27%
EBITDA Margin	-12.35%
Gross margin	20.03%
Gross Profit	$206.1M
Gross Profit Growth Q	888.75%
Net Income	$-296.8M
Net Income Growth Years	0%
Pretax Margin	-27.47%
Profit Margin	-28.85%
Profit Per Employee	$-100,101
ROA	-5.01
Roa5y	-17.34
ROCE	-12.44
ROE	-29.06
Roe5y	-42.95
ROIC	-30.47
Roic5y	-2,147.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-10.65%
Cagr3y	-25.12%
Cagr5y	-0.32%
EPS Growth Years	0
Revenue Growth	64.02x
Revenue Growth Q	64.21x
Revenue Growth Quarters	11x
Revenue Growth Years	4x
Revenue Growth3 Y	106.41x
Revenue Growth5 Y	68.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.6
Assets	$1.7B
Cash	$948.6M
Current Assets	$1.2B
Current Liabilities	$636.4M
Debt	$413.7M
Debt Equity	$0.41
Equity	$1B
Interest Coverage	-6.38
Liabilities	$731.6M
Long Term Assets	$486.6M
Long Term Liabilities	$95.2M
Net Cash	$534.9M
Net Cash By Market Cap	$10.29
Net Cash Growth	-30.71%
Net Debt Equity	$-0.53
Tangible Book Value	$1B
Tangible Book Value Per Share	$5.42
WACC	5.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	29.44
Net Working Capital	$-11.4M
Quick ratio	1.88
Working Capital	$610.7M
Working Capital Turnover	$1.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.8%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-10.65%
200-day SMA	26.69
3Y total return	-58.02%
50-day SMA	20.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-1.61%
All Time High	77.32
All Time High Change	-63.63%
All Time High Date	2023-07-21
All Time Low	16.24
All Time Low Change	73.15%
All Time Low Date	2026-02-04
ATR	1.6
Beta	0.3
Beta1y	1.03
Beta2y	0.78
Ch YTD	29.35
High	29.5
High52	45.3
High52 Date	2025-07-23
High52ch	-37.92%
Low	27.69
Low52	16.24
Low52 Date	2026-02-04
Low52ch	73.15%
Ma50ch	36.52%
Premarket Change Percent	-0.88
Premarket Price	$28.32
Price vs 200-day SMA	5.37%
RSI	71.82
RSI Monthly	44.4
RSI Weekly	61.9
Sharpe ratio	-0.02x
Sortino ratio	0.08
Total Return	-0.8%
Tr YTD	29.35
Tr1m	56.31%
Tr1w	19.2%
Tr3m	64.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	12
Analyst Count Top	5
Analyst Price Target Top	$67.6
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	306,890,256x
Earnings Revenue Estimate Growth	57.34x
Operating Income	$-136.5M
Operating margin	-13.27
Price target	$61.33
Price Target Change	$118
Price Target Change Top	$140

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,696,063%
Float Percent	44.17%
Net Borrowing	-3,600,000
Shares Insiders	0.17%
Shares Institutions	48.18%
Shares Out	184,943,184
Shares Qo Q	0.05%
Shares Yo Y	0.8%
Short Ratio	13.06
Short Shares	26.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-193.4M
Average Volume	2,841,542.95x
Bv Per Share	5.42
CAPEX	$-28.6M
Ch1m	56.31
Ch1w	19.2
Ch1y	-10.65
Ch3m	64.44
Ch3y	-58.02
Ch5y	-1.61
Ch6m	-11.57
Change	-1.58%
Change From Open	-0.95
Close	28.57
Days Gap	-0.63
Depreciation Amortization	9,400,000
Dollar Volume	73,125,525.7
Earnings Date	2026-05-12
Earnings Time	bmo
EBIT	$-136.5M
EBITDA	$-127.1M
EPS	$-1.62
F Score	3
FCF	$-128.8M
FCF EV Yield	-2.76x
FCF Per Share	$-0.7
Financing CF	-300,000
Fiscal Year End	December
Founded	2,014
Income Tax	$14.2M
Investing CF	709,600,000
Ipr	22.26
Iprfo	-24
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	23.61
Ma150ch	19.09%
Ma20	24.05
Ma20ch	16.92%
Net CF	615,200,000
Next Earnings Date	2026-05-12
Open	28.39
Optionable	Yes
Position In Range	23.76
Post Close	28.12
Postmarket Change Percent	-0.43
Postmarket Price	$28
Ppne	401,500,000
Pre Close	28.57
Price Date	2026-05-08
Ptbv Ratio	5.19
Relative Volume	0.92x
Revenue	1,028,900,000x
SBC By Revenue	6.28x
Share Based Comp	64,600,000
Tax By Revenue	1.38x
Tr6m	-11.57%
Us State	New Jersey
Volume	2,600,481
Z Score	4.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LEGN pay a dividend?

Capital-return profile for this ticker.

Performance

LEGN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LEGN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+48.2%

Float: +44.2% of shares outstanding

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LEGN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.8

Above 70: short-term overbought

Price vs 200-day MA

+5.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

-0.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LEGN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LEGN stock rating?

Legend Biotech Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LEGN analysis?

The full report lives at /stocks/LEGN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LEGN?

The latest report frames LEGN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LEGN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.